A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D

NCT06505928 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis D

Interventions

DRUG: hepalatide

Sponsor

Shanghai HEP Pharmaceutical Co., Ltd.